| abstract |
A methylphenidate, including in particular dextro-threo-methylphenide, is administered to a subject to treat a deterioration of the gait or limbs secondary to a genetically acquired disease or processing disorder of pre-frontal cortex, including in particular sclerosis multiple, cerebral palsy, Angelman syndrome, Rett syndrome and fragile X chromosome syndrome. |